Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vemurafenib in Metastatic Melanoma With Brain Metastases
NCT01378975Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2011
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of vemurafenib in melanoma, sponsored by Roche. Started Jul 2011; status: completed.
02
Drugs
vemurafenib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01378975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01378975.